AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

2020-08-25T13:28:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

Educational resources

Webinar banner 3x22

Upcoming Live Webinars

Non-alcoholic steatohepatitis: identification, management, and referral pathways

This webinar has been initiated and commissioned by Intercept Pharma UK and Ireland Ltd and organised in partnership with Guidelines. Intercept Pharma UK and Ireland Ltd has reviewed the scope of the webinar, commissioned the speakers, and approved all materials related to the webinar. The speakers have been paid an ...